Back to top
more

Cerner Corporation (CERN)

(Delayed Data from NSDQ)

$68.47 USD

68.47
2,167,881

+0.46 (0.68%)

Updated May 3, 2019 04:00 PM ET

After-Market: $68.46 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks News

Avanos Medical's (AVNS) App to Support Pain Management Process

Avanos Medical's (AVNS) new solution to help healthcare providers with respect to patients' overall pain management process.

Cerner (CERN) Upgraded to Buy: What Does It Mean for the Stock?

Cerner (CERN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Cerner (CERN) is a Top-Ranked Value Stock: Should You Buy?

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Cerner (CERN) Q3 Earnings and Revenues Surpass Estimates

Cerner's (CERN) third-quarter results benefit from gains across four of its business units.

Cerner (CERN) Tops Q3 Earnings and Revenue Estimates

Cerner (CERN) delivered earnings and revenue surprises of 4.88% and 1.16%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Cerner (CERN) to Report Q3 Earnings: What's in the Offing?

Cerner's (CERN) third-quarter results are likely to reflect gains from strategic deals.

Cerner (CERN) Earnings Expected to Grow: Should You Buy?

Cerner (CERN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Cerner's (CERN) Latest Offering to Improve RCM Portfolio

Cerner's (CERN) latest offering is likely to streamline and automate revenue cycle via interoperability and enhanced usability.

Zacks Industry Outlook Highlights: 10x Genomics, Omnicell, Inspire Medical Systems and Cerner

Zacks Industry Outlook Highlights: 10x Genomics, Omnicell, Inspire Medical Systems and Cerner

Urmimala Biswas headshot

Buy 3 Medical Info Systems Stocks to Brave Industry-wide Challenges

Stocks like 10x Genomics Inc. (TXG), Omnicell, Inc. (OMCL) and Inspire Medical Systems, Inc. (INSP) are expected to gain despite pandemic-led disruptions.

Here's Why You Should Hold on to NextGen (NXGN) Stock Now

NextGen (NXGN) continues to gain momentum on the back of solid demand for its solutions and strength in EHR. However, intense competition woes linger.

Why Cerner (CERN) is a Top Growth Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Here's Why You Should Hold on to NextGen (NXGN) Stock Now

NextGen (NXGN) continues to gain momentum on the back of solid demand for its solutions and strength in EHR. However, intense competition woes linger.

Cerner (CERN) Q2 Earnings and Revenues Surpass Estimates

Cerner's (CERN) second-quarter results benefit from gains across six of its business units.

Cerner (CERN) Q2 Earnings and Revenues Beat Estimates

Cerner (CERN) delivered earnings and revenue surprises of 5.26% and 1.30%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Cerner (CERN) is a Top-Ranked Value Stock: Should You Buy?

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Cerner (CERN) to Report Q2 Earnings: What's in the Offing?

Cerner's (CERN) second-quarter results are likely to reflect gains from strategic deals.

Cerner (CERN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Cerner (CERN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

DexCom (DXCM) to Report Q2 Earnings: What's in the Cards?

DexCom's (DXCM) second-quarter results are likely to reflect rising global awareness of its real-time CGM.

Baxter (BAX) to Report Q2 Earnings: What's in the Cards?

Baxter's (BAX) second-quarter results are likely to reflect growth in its Acute Therapies business.

PerkinElmer (PKI) to Post Q2 Earnings: What's in the Cards?

PerkinElmer's (PKI) second-quarter results are likely to reflect strong performance at Diagnostics segment.

Stryker (SYK) to Report Q2 Earnings: What's in the Cards?

Stryker's (SYK) second-quarter results are likely to reflect strong segmental performances at Medsurg, Orthopaedic and Neurotechnology & Spine.

Cerner (CERN) Extends Partnership to Accelerate Digital Health

Cerner (CERN) expands its partnership with Baystate Health by launching a digital health platform to boost consumer-focused care.

Trina Mukherjee headshot

Digital Health Momentum is Here to Stay: 3 MedTech Stocks in Focus

Here we look at three stocks, MDRX, CERN and RMD, that investors can keep a watch on the back of their robust digital health prospects.

Zacks Industry Outlook Highlights: Computer Programs and Systems, Centogene and Cerner

Zacks Industry Outlook Highlights: Computer Programs and Systems, Centogene and Cerner